Agenda

Return

C. 91

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	July 10, 2018

Contra

Costa

County

Subject:

Amendment to Purchase Order with Aesculap Implant Systems, LLC

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 07/10/2018

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Jaspreet Benepal, 925-370-5101
cc:	Tasha Scott Marcy Wilhelm Jaspreet Benepal

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: July 10, 2018
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Director, an amendment to Purchase Order #F03172 with Aesculap Implant Systems, LLC, to increase the payment limit by $70,000 to a new total payment limit not to exceed $244,000 for the purchase of surgical and medical instruments, tags, cards, neurological implants, disposables and other medical products for the Contra Costa Regional Medical Center (CCRMC) and Health Centers with no change in the original term of February 1, 2016 through January 31, 2019.

FISCAL IMPACT:

100% funding is included in the Hospital Enterprise Fund I budget.

BACKGROUND:

Aesculap Implant Systems, LLC has provided surgical and medical instruments, central line tags and cards, neurological implants, disposables, container supplies and other medical products to CCRMC for more than fifteen years. Invoices are pending due to the increase of buying more products and instruments during the time the California Department of Public Health inspected CCRMC.

CONSEQUENCE OF NEGATIVE ACTION:

If this amendment is not approved, CCRMC will be unable to meet the needs of its surgical patients or meet the State regulatory requirements.